<?xml version='1.0' encoding='utf-8'?>
<document id="18515196"><sentence text="Validation and application of a 96-well format solid-phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of digoxin in human plasma."><entity charOffset="152-159" id="DDI-PubMed.18515196.s1.e0" text="digoxin" /></sentence><sentence text="To evaluate the pharmacokinetics of digoxin in humans, a sensitive and specific LC/MS/MS method was developed and validated for the determination of digoxin concentrations in human plasma"><entity charOffset="36-43" id="DDI-PubMed.18515196.s2.e0" text="digoxin" /><entity charOffset="149-156" id="DDI-PubMed.18515196.s2.e1" text="digoxin" /><pair ddi="false" e1="DDI-PubMed.18515196.s2.e0" e2="DDI-PubMed.18515196.s2.e0" /><pair ddi="false" e1="DDI-PubMed.18515196.s2.e0" e2="DDI-PubMed.18515196.s2.e1" /></sentence><sentence text=" The method was shown to be more sensitive, specific, accurate, and reproducible than common techniques such as RIA" /><sentence text=" For detection, a LC/MS/MS system with electro spray ionization tandem mass spectrometry in the positive ion-multiple reaction-monitoring (MRM) mode was used to monitor precursor to product ions of m/z 798" /><sentence text="5-51" /><sentence text="5 for digoxin and m/z 782"><entity charOffset="6-13" id="DDI-PubMed.18515196.s6.e0" text="digoxin" /></sentence><sentence text="5-35" /><sentence text="5 for the internal standard, digitoxin"><entity charOffset="29-38" id="DDI-PubMed.18515196.s8.e0" text="digitoxin" /></sentence><sentence text=" The method was validated over a concentration range of 0" /><sentence text="02-5 ng/mL and was found to have acceptable accuracy, precision, linearity, and selectivity" /><sentence text=" The mean extraction recovery from spiked plasma samples was above 80%" /><sentence text=" Imidafenacin, coadministered in a drug-drug interaction study, had no detectable influence on the determination of digoxin in human plasma"><entity charOffset="1-13" id="DDI-PubMed.18515196.s12.e0" text="Imidafenacin" /><entity charOffset="116-123" id="DDI-PubMed.18515196.s12.e1" text="digoxin" /><pair ddi="false" e1="DDI-PubMed.18515196.s12.e0" e2="DDI-PubMed.18515196.s12.e0" /><pair ddi="false" e1="DDI-PubMed.18515196.s12.e0" e2="DDI-PubMed.18515196.s12.e1" /></sentence><sentence text=" The novel method was applied to a drug-drug interaction study of digoxin and imidafenacin and the characterization of steady-state pharmacokinetics of digoxin in humans after oral administration at a dose of 0"><entity charOffset="66-73" id="DDI-PubMed.18515196.s13.e0" text="digoxin" /><entity charOffset="78-90" id="DDI-PubMed.18515196.s13.e1" text="imidafenacin" /><entity charOffset="152-159" id="DDI-PubMed.18515196.s13.e2" text="digoxin" /><pair ddi="false" e1="DDI-PubMed.18515196.s13.e0" e2="DDI-PubMed.18515196.s13.e0" /><pair ddi="false" e1="DDI-PubMed.18515196.s13.e0" e2="DDI-PubMed.18515196.s13.e1" /><pair ddi="false" e1="DDI-PubMed.18515196.s13.e0" e2="DDI-PubMed.18515196.s13.e2" /><pair ddi="false" e1="DDI-PubMed.18515196.s13.e1" e2="DDI-PubMed.18515196.s13.e1" /><pair ddi="false" e1="DDI-PubMed.18515196.s13.e1" e2="DDI-PubMed.18515196.s13.e2" /></sentence><sentence text="25 mg on days 1 and 2 followed by 0" /><sentence text="125 mg daily doses on days 3 through 8" /><sentence text="" /></document>